Page last updated: 2024-08-23

mifepristone and Congenital Oculofacial Paralysis, Moebius

mifepristone has been researched along with Congenital Oculofacial Paralysis, Moebius in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Shannon, CS	1
Amram, D; Bos-Thompson, MA; Faillie, JL; Hillaire-Buys, D; Roux, C	1
Darney, PD; Goldberg, AB; Greenberg, MB	1

Reviews

1 review(s) available for mifepristone and Congenital Oculofacial Paralysis, Moebius

Article	Year
Misoprostol and pregnancy. The New England journal of medicine, 2001, Jan-04, Volume: 344, Issue:1 Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Induced; Abortion, Missed; Cervical Ripening; Drug Therapy, Combination; Empirical Research; Female; Government Regulation; Humans; Labor, Induced; Methotrexate; Mifepristone; Misoprostol; Mobius Syndrome; Oxytocics; Postpartum Hemorrhage; Pregnancy; Pregnant Women	2001

Article

Year

Misoprostol and pregnancy.

The New England journal of medicine, 2001, Jan-04, Volume: 344, Issue:1

Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Induced; Abortion, Missed; Cervical Ripening; Drug Therapy, Combination; Empirical Research; Female; Government Regulation; Humans; Labor, Induced; Methotrexate; Mifepristone; Misoprostol; Mobius Syndrome; Oxytocics; Postpartum Hemorrhage; Pregnancy; Pregnant Women

2001

Other Studies

2 other study(ies) available for mifepristone and Congenital Oculofacial Paralysis, Moebius

Article	Year
Comment: analysis of severe adverse events related to the use of mifepristone as an abortifacient. The Annals of pharmacotherapy, 2006, Volume: 40, Issue:6 Topics: Abnormalities, Drug-Induced; Abortifacient Agents, Steroidal; Adult; Female; Humans; Mifepristone; Mobius Syndrome; Pregnancy; Pregnancy Outcome; United States; United States Food and Drug Administration	2006
Möbius syndrome in a neonate after mifepristone and misoprostol elective abortion failure. The Annals of pharmacotherapy, 2008, Volume: 42, Issue:6 Topics: Abnormalities, Drug-Induced; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Humans; Infant, Newborn; Male; Mifepristone; Misoprostol; Mobius Syndrome; Pregnancy; Pregnancy Trimester, First	2008

Article

Year

Comment: analysis of severe adverse events related to the use of mifepristone as an abortifacient.

The Annals of pharmacotherapy, 2006, Volume: 40, Issue:6

Topics: Abnormalities, Drug-Induced; Abortifacient Agents, Steroidal; Adult; Female; Humans; Mifepristone; Mobius Syndrome; Pregnancy; Pregnancy Outcome; United States; United States Food and Drug Administration

2006

Möbius syndrome in a neonate after mifepristone and misoprostol elective abortion failure.

The Annals of pharmacotherapy, 2008, Volume: 42, Issue:6

Topics: Abnormalities, Drug-Induced; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Humans; Infant, Newborn; Male; Mifepristone; Misoprostol; Mobius Syndrome; Pregnancy; Pregnancy Trimester, First

2008